BUTALBITAL

Generic: BUTALBITAL, ACETAMINOPHEN AND CAFFEINE

QUAGEN PHARMACEUTICALS LLCManufacturer
ORALRoute
BUTALBITALActive Substance
2024-02-08Original Approval

BUTALBITAL is FDA application ANDA214288, sponsored by QUAGEN. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Top Reported Reactions

1
HEADACHE
272 reports
2
DRUG INEFFECTIVE
228 reports
3
NAUSEA
218 reports
4
FATIGUE
209 reports
5
PAIN
195 reports
6
COMPLETED SUICIDE
185 reports
7
DIARRHOEA
157 reports
8
MIGRAINE
148 reports
9
TOXICITY TO VARIOUS AGENTS
145 reports
10
DYSPNOEA
135 reports